argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
589.15
-4.32 (-0.73%)
At close: Mar 28, 2025, 4:00 PM
583.60
-5.55 (-0.94%)
Pre-market: Mar 31, 2025, 8:45 AM EDT
argenx SE Revenue
In the year 2024, argenx SE had annual revenue of $2.25B with 77.22% growth. argenx SE had revenue of $757.39M in the quarter ending December 31, 2024, with 81.26% growth.
Revenue (ttm)
$2.25B
Revenue Growth
+77.22%
P/S Ratio
16.22
Revenue / Employee
$1,406,007
Employees
1,599
Market Cap
36.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.25B | 979.61M | 77.22% |
Dec 31, 2023 | 1.27B | 827.58M | 187.66% |
Dec 31, 2022 | 441.01M | -87.25M | -16.52% |
Dec 31, 2021 | 528.27M | 466.31M | 752.59% |
Dec 31, 2020 | 61.96M | -30.85M | -33.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ARGX News
- 24 days ago - argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting - GlobeNewsWire
- 4 weeks ago - argenx SE (ARGX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - argenx: Vyvgart's Sales Momentum Improves, Clinical Data Updates From A Key Competitor Imminent - Seeking Alpha
- 4 weeks ago - argenx Reports Full Year 2024 Financial Results and Provides Fourth Quarter Business Update - GlobeNewsWire
- 4 weeks ago - argenx to Present at TD Cowen 45th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 - GlobeNewsWire
- 2 months ago - argenx Highlights 2025 Strategic Priorities - GlobeNewsWire
- 3 months ago - argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire